GB Sciences, Inc.
GBLX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 754.20K | 1.15M | 1.16M | 1.09M | 1.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.02M | 1.41M | 1.42M | 1.58M | 1.75M |
| Operating Income | -1.02M | -1.41M | -1.42M | -1.58M | -1.75M |
| Income Before Tax | -1.13M | -1.37M | -1.36M | -3.76M | -4.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.13 | -1.37 | -1.36 | -3.76 | -4.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.13M | -1.37M | -1.36M | -3.76M | -4.02M |
| EBIT | -1.02M | -1.41M | -1.42M | -1.58M | -1.75M |
| EBITDA | -1.02M | -1.41M | -1.42M | -1.58M | -1.73M |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.62B | 1.61B | 1.59B | 1.56B | 1.54B |
| Average Diluted Shares Outstanding | 1.62B | 1.61B | 1.59B | 1.56B | 1.54B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |